Episode 59
Biotech Hangout
00:00
The Upspike of BD Deals Between BioFarma and China BioTec
The scale of investment by Chinese BioTecs is off the charts. If you're looking for innovation, particularly given some of the difficulties facing US capital markets, China's a great place to go. We worked on one that was announced today, a company called Lenovo Medicines announced a license of an ADC with AstraZeneca. There are many others that are also happening in the market.
Transcript
Play full episode
